Research into the growth of neurons in the brains of mice at the University of South Florida has led to an unexpected finding: Psilocybin, the psychedelic ingredient of certain mushrooms, might one day help treat post-traumatic stress disorder.
Juan Sanchez-Ramos, a professor of neurology at USF, and a former researcher in his laboratory published their findings this summer in the journal Experimental Brain Research. They were attempting to determine the effects of psilocybin on the creation of new neurons in the brain, which helps learning and the development of short-term memory. It’s a process known as neurogenesis.
Sanchez-Ramos said that in some situations, as when a cancer patient is undergoing chemotherapy, the ability to form new neurons is inhibited.
“One of the important things that we know is that if you destroy the capacity to bring new neurons into being, you will have problems with some aspects of memory,” Sanchez-Ramos said. “One of the side effects (of chemotherapy), besides hair loss … is that you inhibit the birth of new neurons. This can mean memory problems and learning problems.”
He and former Ph.D. student Briony Catlow set out to see if small doses of psilocybin in lab mice affected memory. Catlow is now at the Lieber institute for Brain Development at Johns Hopkins Bioscience Park in Baltimore.
They used a classical conditioning experiment: Mice were introduced into a cubicle. They would hear a tone, then receive a slight shock resembling a static electricity snap, which would lead them to freeze in place.
The researchers then looked for fear conditioning in the mice. How long did it take for them to anticipate the shock after hearing the tone?
The psilocybin did not appear to make a difference in how quickly the mice picked up the fear response. But there was, as Sanchez-Ramos described it, a “serendipitous observation.”
Another measure of classical conditioning is “extinction” — when the tone is sounded but not followed by a shock. How long does it take for the mouse to un-learn the behavior?
The mice that were given the psilocybin doses lost the fear response much faster.
Sanchez-Ramos speculates that perhaps very low doses of psilocybin might help soldiers, for example, recover from PTSD.
Consider how a loud unexpected noise such as a car backfiring might trigger an anxiety episode; might the chemical help that person un-learn the behavior?
Another application might be for drug addicts or alcoholics introduced to an environment — exposed to drug paraphernalia, or entering a bar — that could trigger a relapse. “There’s a lot of classical conditioning with withdrawal symptoms,” Sanchez-Ramos said.
The Latest Google Headlines on:
Posttraumatic stress disorder
[google_news title=”” keyword=”posttraumatic stress disorder” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Posttraumatic stress disorder
- EMA Embarks on Psychedelic Tripon May 10, 2024 at 4:47 am
posttraumatic stress disorder, and end-of-life psychological distress. These compounds include mescaline, N,N-dimethyltryptamine, lysergic acid diethylamide (LSD), and psilocybin. The virtual briefing ...
- Oklahoma FOP applauds bill allowing law enforcement to classify PTSD for workers' compensationon May 9, 2024 at 10:50 pm
Gov. Kevin Stitt recently signed a bill into law that will allow law enforcement to classify post-traumatic stress disorder for workers' compensation.
- Australian study finds link between autism, stress disorderon May 8, 2024 at 7:52 pm
CANBERRA - People with autism are more likely to develop post-traumatic stress disorder (PTSD), Australian research has found. In a new study, researchers from the Australian National University (ANU) ...
- Study Reveals Link Between Autism Spectrum Disorder and PTSDon May 7, 2024 at 8:39 am
For the first time, researchers from the Queensland Brain Institute have proven that a mild stress is enough to trigger post-traumatic stress disorder (PTSD) in mouse models of autism spectrum ...
- Psychedelic compound shows promise in stress relief for socially aggressive miceon April 29, 2024 at 11:01 pm
A study in Neuropharmacology reveals that a single dose of the psychedelic compound (R)-DOI significantly improves stress-coping behaviors and reduces inflammatory markers in mice subjected to social ...
- Dozens of genes are linked to post-traumatic stress disorderon April 21, 2024 at 5:00 pm
Findings underscore that genetic factors contribute to development of the condition after a traumatic incident.
- PTSD: Signs and Symptomson April 17, 2024 at 5:00 pm
But symptoms of posttraumatic stress disorder (PTSD) can pop up months or even years later. Unlike a rash or broken arm, PTSD can be tough to identify, especially when it's happening in your own mind.
- Post Traumatic Stress Disorder News and Researchon April 11, 2024 at 5:00 pm
Researchers have adapted an artificial intelligence (AI) program to identify signs of childbirth-related post-traumatic stress disorder (CB-PTSD) by evaluating short narrative statements of ...
- Post Traumatic Stress Disorderon April 9, 2024 at 5:00 pm
A new study presented at the European Psychiatric Association Congress 2024 reveals a significant rise in mental health issues among children and adolescents displaced by the war in Ukraine. The ...
The Latest Google Headlines on:
PTSD treatment
[google_news title=”” keyword=”PTSD treatment” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
PTSD treatment
- Older Veterans with cognitive difficulties could mistakenly be diagnosed with Alzheimer's when PTSD is root causeon May 9, 2024 at 12:36 pm
A new study has investigated how measures of thinking, memory, and Alzheimer's disease risk group together in Veterans aged 65 and older without dementia. Results of the study showed multiple patterns ...
- Governor Stitt signs PTSD bill: A victory for police mental healthon May 9, 2024 at 8:11 am
Governor Kevin Stitt signed new post-traumatic stress disorder (PTSD) bill, SB 1457, into law for the Oklahoma Fraternal Order of Police (OK FOP).This bill woul ...
- Investors Warm Up to Psychedelics as FDA Reviews Treatment for PTSDon May 9, 2024 at 5:40 am
Plus, a key decision expected this summer from the US Food and Drug Administration on whether to authorize MDMA (also known as ecstasy) to treat PTSD could help push investment in the industry more ...
- US FDA panel to discuss first psychedelic-assisted PTSD treatment next month (May 6)on May 8, 2024 at 8:58 am
The U.S. Food and Drug Administration's panel of independent advisers will on June 4 deliberate whether they should recommend approval for the first MDMA-assisted therapy for post-traumatic stress ...
- FDA to consider MDMA as treatment for PTSDon May 8, 2024 at 8:25 am
An FDA panel of independent advisers is set to consider the first potential new post-traumatic stress disorder treatment in 25 years — MDMA — NBC News reported May 7. MDMA, more commonly known as ...
- Lykos Therapeutics’ MDMA Therapy for PTSD to Face FDA Adcommon May 8, 2024 at 6:04 am
As interest in psychedelic therapies ramp up, Lykos Therapeutics will go in front of the FDA’s Psychopharmacologic Drugs Advisory Committee on June 4 to present its investigational treatment for ...
- The FDA could approve MDMA therapy for PTSD treatmenton May 8, 2024 at 5:39 am
As a means to help those with post-traumatic stress disorder, a Food and Drug Administration panel of independent advisers will discuss whether or not MDMA-assisted therapy should be approved for a ...
- Air Force Pilots Now Can Start Mental Health Treatment and Won't Immediately Be Pulled from Flight Statuson May 7, 2024 at 3:50 pm
Prior to the policy update, which was publicized in a May 1 press release, if an airman began seeking treatment for mental health-related illnesses or concerns, they would then need a return-to-duty ...
- Postpartum PTSD: Right Diagnosis Can Help Mothers and Babieson May 7, 2024 at 12:39 pm
“A woman may feel like she has failed for not being able to have a vaginal delivery,” Dekel said. “In some cases, postpartum PTSD can also become a disincentive for future pregnancy. It leads to ...
- Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatmenton May 7, 2024 at 12:46 am
The global market for PTSD treatment, valued at $16.8 billion in 2023, is expected to reach $27.37 billion by 2033, according to Future Market Insights. Existing treatment options like SSRIs and SNRIs ...